Evidence map›Paper›PMID 19888833›Full record

ReviewAntioxidants & redox signaling2010

Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Irena Levitan, Suncica Volkov, Papasani V Subbaiah

Abstract readReview
In one paragraph

Review in Antioxidants & redox signaling, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 191 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
191citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

191 citing papers in PubMed, 1 synthesis or guideline pooled it, 457 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Implications ofAntioxidants (Basel, Switzerland) · 2025
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Discovery andFrontiers in immunology · 2025
    Article

131 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Irena LevitanSection of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA. levitan@uic.edu
Suncica Volkov
Papasani V Subbaiah
University of Illinois Chicago · US

Funding

Cholesterol Regulation of Endothelial K+ ChannelsR01HL073965 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LEVITAN, IRENA · 2004 to 2024
$7.3M
Impact of dyslipidemia on endothelial biomechanicsR01HL083298 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LEVITAN, IRENA, MINSHALL, RICHARD D · 2007 to 2021
$7.0M
ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISMR01HL068585 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SUBBAIAH, PAPASANI V · 2002 to 2012
$3.3M
Physiological Significance of Conjugated Double Bonds in Membrane LipidsR21DK078165 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SUBBAIAH, PAPASANI V · 2008 to 2009
$432k
Role of Sphingomyelin in Lipoprotein MetabolismR56HL068585 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SUBBAIAH, PAPASANI V · 2008 to 2008
$393k
NHLBI NIH HHS HL073965NHLBI NIH HHS HL083298NHLBI NIH HHS HL 68585NHLBI NIH HHS R01 HL068585NHLBI NIH HHS R01 HL073965NHLBI NIH HHS R01 HL083298NIDDK NIH HHS DK 078165NIDDK NIH HHS R21 DK078165
6 · The paper itself

Abstract

Oxidative modification of LDL is known to elicit an array of pro-atherogenic responses, but it is generally underappreciated that oxidized LDL (OxLDL) exists in multiple forms, characterized by different degrees of oxidation and different mixtures of bioactive components. The variable effects of OxLDL reported in the literature can be attributed in large part to the heterogeneous nature of the preparations employed. In this review, we first describe the various subclasses and molecular composition of OxLDL, including the variety of minimally modified LDL preparations. We then describe multiple receptors that recognize various species of OxLDL and discuss the mechanisms responsible for the recognition by specific receptors. Furthermore, we discuss the contentious issues such as the nature of OxLDL in vivo and the physiological oxidizing agents, whether oxidation of LDL is a prerequisite for atherogenesis, whether OxLDL is the major source of lipids in foam cells, whether in some cases it actually induces cholesterol depletion, and finally the Janus-like nature of OxLDL in having both pro- and anti-inflammatory effects. Lastly, we extend our review to discuss the role of LDL oxidation in diseases other than atherosclerosis, including diabetes mellitus, and several autoimmune diseases, such as lupus erythematosus, anti-phospholipid syndrome, and rheumatoid arthritis.

Indexed as

AnimalsAtherosclerosisAutoimmune DiseasesDiabetes MellitusHumansLipoproteins, LDLOxidation-ReductionReactive Oxygen SpeciesLipoproteins, LDLReactive Oxygen Species

Identifiers

PMID19888833
PMCPMC2877120
OpenAlexW2049746695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.